Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer
Clinical trial NCT00320710 · COMPLETED
Trial details
- NCT number
- NCT00320710
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2013-07-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.